Life ScienceCompany
Taro Pharmaceutical Industries M&A Summary
Taro Pharmaceutical Industries has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2016, when it sold Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS to Strongbridge Biopharma for $9M. Taro Pharmaceutical Industries has acquired in 1 US state. The Company’s most targeted sectors include consumer products (100%).
Taro Pharmaceutical Industries Business Overview
Where is Taro Pharmaceutical Industries headquartered?
Taro Pharmaceutical Industries is headquartered in Haifa Bay, Israel.
What is Taro Pharmaceutical Industries’ revenue?
Taro Pharmaceutical Industries disclosed revenue of 561M USD for 2022 and 549M USD for 2021.
How many employees does Taro Pharmaceutical Industries have?
Taro Pharmaceutical Industries has 1,455 employees.
What sector is Taro Pharmaceutical Industries in?
Taro Pharmaceutical Industries is a life science company.
When was Taro Pharmaceutical Industries founded?
Taro Pharmaceutical Industries was founded in 1950.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2